Hiroaki Sunaga

1.1k citations

33 papers · 799 indexed · h-index 17

Molecular Biology
Physiology top 10%
Cardiology and Cardiovascular Medicine top 10%
Pulmonary and Respiratory Medicine
Epidemiology

Co-authors: Masahiko Kurabayashi Tatsuya Iso Hiroki Matsui Tomoyuki Yokoyama Norimichi Koitabashi Masaru Obokata Mas Rizky A. A. Syamsunarno Hirofumi Hanaoka
Topics: Cardiovascular Function and Risk Factors (13 papers)Peroxisome Proliferator-Activated Receptors (11 papers)Adipose Tissue and Metabolism (7 papers)
Cited by: Physiology Cardiology and Cardiovascular Medicine Nephrology
Journals: Circulation Nature Communications PLoS ONE
Partner nations: Japan Indonesia Australia

In The Last Decade

Hiroaki Sunaga

32 papers receiving 794 citations

Peers

Countries citing papers authored by Hiroaki Sunaga

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Sunaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Sunaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Sunaga more than expected).

Fields of papers citing papers by Hiroaki Sunaga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Sunaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Sunaga. The network helps show where Hiroaki Sunaga may publish in the future.

Co-authorship network of co-authors of Hiroaki Sunaga

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Sunaga. A scholar is included among the top collaborators of Hiroaki Sunaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Sunaga. Hiroaki Sunaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic Impact of Fibroblast Growth Factor 21 in Patients With Heart Failure 2025 ·Circulation Reports ·Hiroaki Sunaga,Kuniko Yoshida,Kazuki Kagami,Tomonari Harada,(unknown),(unknown),Hiroki Matsui,Keiko Kawai‐Kowase,Tatsuya Iso,Tomoyuki Yokoyama,Masahiko Kurabayashi,Hideki Ishii,Masaru Obokata	0
2	Sacubitril/valsartan improves diastolic left ventricular stiffness with increased titin phosphorylation via cGMP-PKG activation in diabetic mice 2024 ·Scientific Reports ·(unknown),Hiroki Matsui,Hiroaki Sunaga,Kohzo Nagata,Masaaki Hirayama,Hideru Obinata,Tomoyuki Yokoyama,(unknown),Masahiko Kurabayashi,Norimichi Koitabashi	4
3	Pathophysiologic Contributions of Visceral Adiposity to Left Ventricular Diastolic Dysfunction 2023 ·Journal of Cardiovascular Development and Disease ·(unknown),Masaru Obokata,(unknown),Hiroki Matsui,Y. Seki,Takamichi Igarashi,Hiroaki Sunaga,Ryo Kawakami,Tomonari Harada,Kazuki Kagami,Hiroshi Saeki,Ken Shirabe,Tatsuya Iso,Hideki Ishii	2
4	Ketone body and FGF21 coordinately regulate fasting-induced oxidative stress response in the heart 2022 ·Scientific Reports ·Ryo Kawakami,Hiroaki Sunaga,Tatsuya Iso,Ryosuke Kaneko,Norimichi Koitabashi,Masaru Obokata,Tomonari Harada,Hiroki Matsui,Tomoyuki Yokoyama,Masahiko Kurabayashi	11
5	Urinary FABP1 is a biomarker for impaired proximal tubular protein reabsorption and is synergistically enhanced by concurrent liver injury 2021 ·The Journal of Pathology ·Ryo Kawakami,(unknown),Ayumu Konno,Ryosuke Kaneko,Shreya Shrestha,(unknown),Hiroaki Sunaga,Hirofumi Hanaoka,Sawako Goto,Michihiro Hosojima,Hideyuki Kabasawa,Masaru Obokata,Norimichi Koitabashi,Hiroki Matsui,Tsutomu Sasaki,Akihiko Saito,Motoko Yanagita,Hirokazu Hirai,Masahiko Kurabayashi,Tatsuya Iso	8
6	Reduced Fatty Acid Use from CD36 Deficiency Deteriorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice 2021 ·Metabolites ·(unknown),Ryo Kawakami,Mas Rizky A. A. Syamsunarno,Hideru Obinata,Aiko Yamaguchi,Hirofumi Hanaoka,Takako Hishiki,Noriyo Hayakawa,Norimichi Koitabashi,Hiroaki Sunaga,Hiroki Matsui,Masahiko Kurabayashi,Tatsuya Iso	4
7	Prognostic Impact of Elevated Fatty Acid-Binding Protein 1 in Patients with Heart Failure 2021 ·ESC Heart Failure ·Kazuki Kagami,Hiroaki Sunaga,Hidemi Sorimachi,Tomonari Harada,Kuniko Yoshida,Toshimitsu Kato,Koji Kurosawa,Ryo Kawakami,Norimichi Koitabashi,Tatsuya Iso,Takeshi Adachi,Masahiko Kurabayashi,Masaru Obokata	5
8	Pathophysiological and diagnostic importance of fatty acid-binding protein 1 in heart failure with preserved ejection fraction 2021 ·Scientific Reports ·Tomonari Harada,(unknown),Hiroaki Sunaga,Kazuki Kagami,Kuniko Yoshida,Toshimitsu Kato,Ryo Kawakami,(unknown),Naoki Wada,Tatsuya Iso,Masahiko Kurabayashi,Masaru Obokata	4
9	Pathophysiological Role of Fatty Acid-Binding Protein 4 in Asian Patients with Heart Failure and Preserved Ejection Fraction 2020 ·ESC Heart Failure ·Tomonari Harada,Hiroaki Sunaga,Hidemi Sorimachi,Kuniko Yoshida,Toshimitsu Kato,Koji Kurosawa,(unknown),Norimichi Koitabashi,Tatsuya Iso,Masahiko Kurabayashi,Masaru Obokata	27
10	DPP-4 inhibitor induces FGF21 expression via sirtuin 1 signaling and improves myocardial energy metabolism 2020 ·Heart and Vessels ·(unknown),Norimichi Koitabashi,Hiroki Matsui,Hiroaki Sunaga,(unknown),Mas Rizky A. A. Syamsunarno,Aiko Yamaguchi,Masaru Obokata,Hirofumi Hanaoka,Tomoyuki Yokoyama,Masahiko Kurabayashi	21
11	Exercise endurance capacity is markedly reduced due to impaired energy homeostasis during prolonged fasting in FABP4/5 deficient mice 2019 ·BMC Physiology ·Tatsuya Iso,(unknown),Hiroaki Sunaga,(unknown),Hiroki Matsui,Rina Tanaka,(unknown),Mas Rizky A. A. Syamsunarno,Tomoyuki Yokoyama,Masahiko Kurabayashi	5
12	Reduced transient receptor potential vanilloid 2 expression in alveolar macrophages causes COPD in mice through impaired phagocytic activity 2019 ·BMC Pulmonary Medicine ·(unknown),Manabu Ueno,Toshitaka Maeno,Koichi Yamaguchi,Kenichiro Hara,Hiroaki Sunaga,Hiroki Matsui,Masahiro Nagasawa,Itaru Kojima,Yuko Iwata,Shigeo Wakabayashi,Masahiko Kurabayashi	13
13	Myocardial fatty acid uptake through CD36 is indispensable for sufficient bioenergetic metabolism to prevent progression of pressure overload-induced heart failure 2018 ·Scientific Reports ·(unknown),Mas Rizky A. A. Syamsunarno,Norimichi Koitabashi,Hideru Obinata,Aiko Yamaguchi,Hirofumi Hanaoka,Takako Hishiki,Noriyo Hayakawa,Motoaki Sano,Hiroaki Sunaga,Hiroki Matsui,Yoshito Tsushima,Makoto Suematsu,Masahiko Kurabayashi,Tatsuya Iso	33
14	Robust suppression of cardiac energy catabolism with marked accumulation of energy substrates during lipopolysaccharide-induced cardiac dysfunction in mice 2017 ·Metabolism ·(unknown),Mas Rizky A. A. Syamsunarno,Hideru Obinata,Aiko Yamaguchi,Hiroaki Sunaga,Hiroki Matsui,Takako Hishiki,Tomomi Matsuura,Norimichi Koitabashi,Masaru Obokata,Hirofumi Hanaoka,Anwarul Haque,Fumio Kunimoto,Yoshito Tsushima,Makoto Suematsu,Masahiko Kurabayashi,Tatsuya Iso	33
15	Serum levels of fatty acid binding protein 4 and fat metabolic markers in relation to catecholamines following exercise 2017 ·Clinical Biochemistry ·Tatsuya Iso,Hiroaki Sunaga,Hiroki Matsui,Shu Kasama,(unknown),(unknown),(unknown),Kiyomi Nakajima,Tetsuo Machida,Masami Murakami,Tomoyuki Yokoyama,Masahiko Kurabayashi	19
16	Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients 2016 ·American Heart Journal ·Masaru Obokata,Hiroaki Sunaga,Hideki Ishida,Kyoko Ito,Tetsuya Ogawa,Yukio Ando,Masahiko Kurabayashi,Kazuaki Negishi	43
17	CD36 is indispensable for thermogenesis under conditions of fasting and cold stress 2015 ·Biochemical and Biophysical Research Communications ·(unknown),Mas Rizky A. A. Syamsunarno,Tatsuya Iso,Aiko Yamaguchi,Hirofumi Hanaoka,Hiroaki Sunaga,Norimichi Koitabashi,Hiroki Matsui,Chiho Yamazaki,Satomi Kameo,Yoshito Tsushima,Tomoyuki Yokoyama,Hiroshi Koyama,Nada A. Abumrad,Masahiko Kurabayashi	64
18	Fatty Acid Binding Protein 4 and 5 Play a Crucial Role in Thermogenesis under the Conditions of Fasting and Cold Stress 2014 ·PLoS ONE ·Mas Rizky A. A. Syamsunarno,Tatsuya Iso,Aiko Yamaguchi,Hirofumi Hanaoka,(unknown),Masaru Obokata,Hiroaki Sunaga,Norimichi Koitabashi,Hiroki Matsui,Kazuhisa Maeda,Keigo Endo,Yoshito Tsushima,Tomoyuki Yokoyama,Masahiko Kurabayashi	33
19	Deranged fatty acid composition causes pulmonary fibrosis in Elovl6-deficient mice 2013 ·Nature Communications ·Hiroaki Sunaga,Hiroki Matsui,Manabu Ueno,Toshitaka Maeno,Tatsuya Iso,Mas Rizky A. A. Syamsunarno,(unknown),Takashi Matsuzaka,Hitoshi Shimano,Tomoyuki Yokoyama,Masahiko Kurabayashi	87
20	Stearoyl-CoA Desaturase-1 (SCD1) Augments Saturated Fatty Acid-Induced Lipid Accumulation and Inhibits Apoptosis in Cardiac Myocytes 2012 ·PLoS ONE ·Hiroki Matsui,Tomoyuki Yokoyama,Kenichi Sekiguchi,(unknown),Hiroaki Sunaga,(unknown),Manabu Ueno,Tatsuya Iso,Masashi Arai,Masahiko Kurabayashi	73

About Hiroaki Sunaga

Hiroaki Sunaga is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Nephrology, having authored 33 papers that have together received 799 indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (13 papers), Peroxisome Proliferator-Activated Receptors (11 papers) and Adipose Tissue and Metabolism (7 papers). The work is most often cited by research in Physiology (243 citations), Cardiology and Cardiovascular Medicine (210 citations) and Nephrology (57 citations). Hiroaki Sunaga has collaborated with scholars based in Japan, Indonesia and Australia. Frequent co-authors include Masahiko Kurabayashi, Tatsuya Iso, Hiroki Matsui, Tomoyuki Yokoyama, Norimichi Koitabashi, Masaru Obokata, Mas Rizky A. A. Syamsunarno, Hirofumi Hanaoka, Aiko Yamaguchi and Manabu Ueno. Their work appears in journals such as Circulation, Nature Communications and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact